Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert.
about
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophreniaMolecular substrates of schizophrenia: homeostatic signaling to connectivityPotential primary roles of glial cells in the mechanisms of psychiatric disorders.15N-labeled brain enables quantification of proteome and phosphoproteome in cultured primary neurons.Contribution of nonprimate animal models in understanding the etiology of schizophrenia.Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches.The myelin-pathogenesis puzzle in schizophrenia: a literature review.Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.Gene expression profiling in rodent models for schizophrenia.Reticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases.RNT4 3'-UTR insertion/deletion polymorphisms are not associated with atrial septal defect in Chinese Han population: a brief communication.A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates.Genetics of developmental psychiatric disorders: pathways to discoveryGenetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility.White matter in learning, cognition and psychiatric disordersNogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortexNogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns.Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.Understanding aberrant white matter development in schizophrenia: an avenue for therapy?Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities.Glia-related genes and their contribution to schizophrenia.New Insights into the Roles of Nogo-A in CNS Biology and Diseases.Multimodal Neuroimaging in Schizophrenia: Description and Dissemination.N-Methyl-d-Aspartate Receptor - Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia.Spatiotemporal and Long Lasting Modulation of 11 Key Nogo Signaling Genes in Response to Strong Neuroexcitation.Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.Age-dependent decline of nogo-a protein in the mouse cerebrum.Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk.
P2860
Q24670103-1A0609A5-254D-44D2-9498-104315797856Q30383611-DB7DD053-1327-4D5D-A286-900CC2856177Q30410688-CADF5268-C06E-4046-8239-320CB89F6EF2Q30458503-05D4E711-089F-487B-AE1C-60937CFA8F64Q30474963-95C4A298-1D0C-42E1-B13E-6D9D981FE9C6Q30499718-9ACC8FE5-E759-406C-AE1B-AF58088E5FE9Q33344726-E40C89A9-409E-4BB7-A979-865109B9C831Q33715071-E5B75D2A-CD0E-41FA-855F-84B5ABDA1181Q34829319-65A33A84-21BF-41E7-AE41-C3BD2D3D54A8Q36010989-DE99CF2A-4C13-47A3-8BC9-E338B209E23AQ36045193-F24316C4-A32C-4668-BC05-2CA0DA214150Q36059047-1FF2DF0D-E4CE-4789-8B39-22A0B93859A9Q36253011-AE9AAB69-547F-4E88-8BAB-18D1D35DA434Q36323754-32A5EB5B-E8F1-478A-BC32-0CC103D0B948Q36793946-60EB3388-CEAB-4838-8228-C2095A567469Q37141293-24D64C82-A8B6-426E-A368-50AC4666E917Q37564007-198563F5-7422-41D1-B1D2-8FE0028907B1Q37642580-4403C313-A34D-4C96-8A4A-7FB88C6BA8A1Q37800531-94DBE612-D2C0-438D-8B24-CC2E35E8052BQ37896626-EDDCC057-10C2-4B00-B606-C43EE2363DB4Q38183367-5E29B4A1-80C2-4694-A0A8-BE7231A44520Q38373219-021B3C69-BF5E-44DC-8F6A-5AA7FD89BE36Q38565299-65AA6BFA-117C-42D1-8A8B-C1220825D599Q38622665-8B8DA34A-0200-476E-9143-0250D18470CDQ41823071-92B862E1-DF72-4A3C-9304-2D5C77240E39Q42014342-5A85AED8-C108-41C1-955F-C0BC4BBC61ECQ43488978-D5F6A4C5-6C6E-4F1F-AB70-B548837DA052Q48628174-1524F701-5228-4AB3-BC5B-D86580203AC8Q50122927-C9A94CA4-DB14-4B3D-AD83-449358F790D5Q54129822-CD7FBC78-E758-4D37-A2B6-4240880838EE
P2860
Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@ast
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@en
type
label
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@ast
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@en
prefLabel
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@ast
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@en
P2093
P1476
Schizophrenia and Nogo: elevat ...... ce of a homozygous CAA insert.
@en
P2093
P304
P356
10.1016/S0169-328X(02)00492-8
P577
2002-11-01T00:00:00Z